Archive for the ‘dementia’ Category

Pain Relievers Appear Ineffective In Preventing Alzheimer’s In The Very Elderly

ScienceDaily (Apr. 23, 2009) — A new study shows that nonsteroidal anti-inflammatory drugs (NSAIDs), such as the pain relievers ibuprofen and naproxen, do not prevent Alzheimer’s disease or other forms of dementia. Instead, the risk of developing dementia in the study’s very elderly population (most were over age 83 when they developed dementia) was 66 [...]

Continue reading »

Feeding Tubes and Advanced Dementia?

Do Feeding Tubes Help Or Harm In Advanced Dementia?
ScienceDaily (Apr. 15, 2009) — Family members grappling with the decision to allow a feeding tube for a relative with advanced dementia will find little comfort from a new review of evidence.
Poor food intake is common in individuals with dementia for a variety of reasons. In advanced [...]

Continue reading »

Possible Alzheimer’s/Epilepsy Connection

 Alzheimer’s and Epilepsy Connection:  New Research
Medical News Today, March 20, 2009
Alzheimer’s Society comment on new research in the Journal of Neuroscience investigating the link between Alzheimer’s and Epilepsy.
‘This research enhances our understanding of the relationship between epilepsy and dementia. People with early-onset Alzheimer’s have an increased risk of epileptic seizures and Alzheimer’s Society research shows [...]

Continue reading »

Newer Antipsychotics Pose Cardiac Risk

Patients advised to avoid the drugs in some cases
WEDNESDAY, Jan. 14 (HealthDay News) – A new study warns that the second generation of antipsychotic drugs, used to treat conditions ranging from schizophrenia to anxiety, put patients at higher risk of sudden death due to cardiac arrest.
The odds of a heart problem are low, and specialists [...]

Continue reading »

Older Women Who Are More Physically Fit Have Better Cognitive Function

ScienceDaily (Jan. 8, 2009) — New research by Marc Poulin, PhD, DPhil, finds that being physically fit helps the brain function at the top of its game. An Alberta Heritage Foundation for Medical Research Senior Scholar, Poulin finds that physical activity benefits blood flow in the brain, and, as a result, cognitive abilities.
“Being sedentary is [...]

Continue reading »

Scientists Make Strides Toward Defining Genetic Signature Of Alzheimer’s Disease

ScienceDaily (Jan. 5, 2009) — Scientists have new information about the complex genetic signature associated with Alzheimer’s disease, the leading cause of cognitive decline and dementia in the elderly. The research, published by Cell Press in the January issue of the American Journal of Human Genetics, uses a powerful, high-resolution analysis to look for genes [...]

Continue reading »

Alzheimer’s Drugs Also Treat Behavioral, Psych Problems

Therapy effective at same dosage used to improve cognitive impairment, study says
By Robert Preidt
WEDNESDAY, Dec. 17 (HealthDay News) — Drugs used to treat Alzheimer’s patients’ cognitive symptoms are also a safe and effective therapy for behavioral and psychological symptoms such as aggression, wandering and paranoia, according to U.S. researchers.
They reviewed nine studies that examined [...]

Continue reading »

Dementia Deaths & Mortality Stats

Under-reported Dementia Deaths Raises Questions About Accuracy Of Mortality Statistics
 
ScienceDaily (Dec. 16, 2008) — Deaths due to dementia and Alzheimer’s disease are underreported on death certificates, according to a study conducted by Hebrew SeniorLife’s Institute for Aging Research (IFAR), raising concerns about the accuracy of mortality statistics based on these documents.
According to the National Center [...]

Continue reading »

Aerobic activity may reverse mental decline

NEW YORK (Reuters Health) – October 17, 2008 – Regular aerobic exercise can not only stave off the decline in brain function that often comes with age, it can also help turn back the clock on brain aging, two experts in the field report, based on a critical review of published studies.
 Age-related deterioration in the [...]

Continue reading »

SOCIAL TIES DELAY MEMORY LOSS IN THE AGED

 
NEW YORK (Reuters Health) – May 29, 2008 – Staying connected with family and friends may delay memory decline among the elderly, new research confirms.
“Our results suggest that increasing social integration may be an important component of efforts to protect older Americans from memory decline,” Dr. Lisa F. Berkman from the Department of Society, Human [...]

Continue reading »

Ibuprofen, Aspirin, Naproxen May Be Equally Effective At Reducing Risk of Alzheimer’s Disease

(ScienceDaily) – May 30, 2008 — Different types of non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, naproxen, and aspirin, appear to be equally effective in lowering the risk of Alzheimer’s disease, according to the largest study of its kind published in the May 28, 2008, online issue of Neurology®, the medical journal of the American [...]

Continue reading »

Low B12 Tied To Faster Mental Decline With Age

November 26, 2007 – NEW YORK (Reuters Health) – Low levels of vitamin B12 could speed mental decline in older people, a new study suggests.
Among a group of men and women aged 65 and older, those whose levels of two B12 activity markers indicated higher blood levels of the vitamin had a slower drop-off in [...]

Continue reading »

Alzheimer’s Patients Unresponsive to Antipsychotics

By Will Boggs, MD
Thursday, November 15, 2007 – NEW YORK (Reuters Health) – Second-generation antipsychotic drugs are no better than placebo — from a cost-benefit viewpoint — for treating the psychosis and aggression that can develop in Alzheimer disease patients, according to a report in the Archives of General Psychiatry.
“These drugs do not generate enough [...]

Continue reading »

Antidepressant Helps Dementia Symptoms

Source:  http://www.sciencedaily.com
TORONTO, Sept. 10 (UPI) — Researchers in Canada found an antidepressant preformed as well as an often prescribed anti-psychotic for dementia patients — but with fewer side effects.
The study, published in the American Journal of Geriatric Psychiatry, compared the efficacy and safety of the antidepressant citalopram and the anti-psychotic risperidone in alleviating agitation and [...]

Continue reading »